Welcome to the 7th Annual Biomedical Forum. This year’s program will focus on the FDA regulatory issues and the latest innovations in medical device industry, as well as business strategy and opportunities to thrive in the new economy amid global financial challenges. The mission of this forum is to provide an attractive platform for entrepreneurs, scientists, engineers, investors, executives, and policy makers to promote life sciences, biotechnology, pharmaceutical, medical device and alliances across the biomedical industry in Southern California and Asia. The annual biomedical forum is one of the flagship events organized by SABPA OC/LA, which consistently attracted more than 200 attendees. This year, we have brought to you FDA officials and seasoned regulatory affair experts, as well as exhilarating entrepreneurs that help accelerate the development of technology into clinical practices. I hope you will enjoy the program.
Fred Ouyang, PhD, MBA
President, SABPA OC/LA
a:21:{i:0;a:3:{s:12:"time_program";s:7:"8:00 am";s:19:"description_program";s:0:"";s:7:"program";s:34:"Registration
Coffee and Breakfast";}i:1;a:3:{s:12:"time_program";s:8:"8:50 am ";s:19:"description_program";s:45:"Fred Ouyang, PhD, MBA, President, SABPA OC/LA";s:7:"program";s:15:"Opening Remarks";}i:2;a:3:{s:12:"time_program";s:9:"Session I";s:19:"description_program";s:68:"Moderator: Yan-Bo Yang, PhD,
Executive Vice President, SABPA OC/LA";s:7:"program";s:26:"Pharmaceutical Development";}i:3;a:3:{s:12:"time_program";s:7:"9:00 am";s:19:"description_program";s:48:"Dave Chesney
Vice President, PAREXEL Consulting";s:7:"program";s:57:"Current FDA Inspection Trends, National and International";}i:4;a:3:{s:12:"time_program";s:7:"9:40 am";s:19:"description_program";s:40:"Jinsong Ni, PhD
Director, Allergan Inc.";s:7:"program";s:110:"Ocular Drug Discovery and Development and Life Cycle Management: Stories of Alphagan® and Lumigan® Franchise";}i:5;a:3:{s:12:"time_program";s:8:"10:20 am";s:19:"description_program";s:0:"";s:7:"program";s:12:"Coffee Break";}i:6;a:3:{s:12:"time_program";s:8:"10:50 am";s:19:"description_program";s:90:"Aryo Nikopour,
Vice President of Scientific and Technical Services, Irvine Pharmaceutical";s:7:"program";s:58:"Systematic approach to Extractables and Leachables Studies";}i:7;a:3:{s:12:"time_program";s:10:"Session II";s:19:"description_program";s:13:"Moderator:TBD";s:7:"program";s:8:"Industry";}i:8;a:3:{s:12:"time_program";s:8:"11:20 am";s:19:"description_program";s:59:"Virginia A. Lang, PhD
Principal and founder of HirLan, Inc";s:7:"program";s:108:"The new Human Factors Compliance: An FDA requirement and essential business strategy for biomedical products";}i:9;a:3:{s:12:"time_program";s:8:"11:50 am";s:19:"description_program";s:0:"";s:7:"program";s:22:"Sponsors appreciations";}i:10;a:3:{s:12:"time_program";s:8:"12:00 am";s:19:"description_program";s:0:"";s:7:"program";s:5:"Lunch";}i:11;a:3:{s:12:"time_program";s:7:"1:00 pm";s:19:"description_program";s:57:"Agnes Juang, PhD, JD
Knobbe, Martens, Olson & Bear, LLP ";s:7:"program";s:44:"IP Considerations during Product Development";}i:12;a:3:{s:12:"time_program";s:7:"1:30 pm";s:19:"description_program";s:57:"Z. Y. James Fang, PhD, Partner
Davis Wright Tremaine LLP";s:7:"program";s:52:"From Idea to IPO in China, Some Legal Considerations";}i:13;a:3:{s:12:"time_program";s:7:"2:00 pm";s:19:"description_program";s:115:"Kristy Hua, MHA
Business Development Officer, North American Representative Office of Shenzhen, P.R. China (NAROS)";s:7:"program";s:59:"Shenzhen, China’s City of Innovation and Entrepreneurship";}i:14;a:3:{s:12:"time_program";s:7:"2:20 PM";s:19:"description_program";s:0:"";s:7:"program";s:12:"Coffee Break";}i:15;a:3:{s:12:"time_program";s:11:"Session III";s:19:"description_program";s:60:"Moderator: Caroline Cheung, President at Allied Intrade Inc.";s:7:"program";s:44:"Innovation in Medical Device and Diagnostics";}i:16;a:3:{s:12:"time_program";s:7:"2:50 pm";s:19:"description_program";s:94:"Taosheng Huang, PhD
Associate Professor, School of Medicine, University of California, Irvine";s:7:"program";s:78:"Application of Novel Genomic Technologies in CLIA Certified Genetic Laboratory";}i:17;a:3:{s:12:"time_program";s:6:"3:20PM";s:19:"description_program";s:77:"Dena Emmerson
Researcher, Institute for Conservation Research, San Diego Zoo";s:7:"program";s:82:"Bioinspired at San Diego Zoo Global: Biomedical Inspiration from the Natural World";}i:18;a:3:{s:12:"time_program";s:7:"3:50 pm";s:19:"description_program";s:54:"Kenneth Chung
Director of R&D, Sharklet Technologies ";s:7:"program";s:36:"Sharkskin Inspired Bacterial Control";}i:19;a:3:{s:12:"time_program";s:7:"4:20 pm";s:19:"description_program";s:78:"Yan-Bo Yang, PhD
Director, Pharmaceutical Development, B. Braun Medical Inc. ";s:7:"program";s:15:"Closing Remarks";}i:20;a:3:{s:12:"time_program";s:7:"4:30 pm";s:19:"description_program";s:0:"";s:7:"program";s:15:"Meeting adjourn";}}
Registration (Lunch included)
$30 for pre-registration
$15 for students and post-docs
$40 for onsite registration
SABPA OCLA
